Mission Boost Grants (MBG)
Mission Boost Grants fund research that moves promising cancer discoveries from the lab toward human clinical trials, aiming to speed up the development of new cancer therapies.
Funder: American Cancer Society
Due Dates: December 1, 2026 | June 1, 2027
Funding Amounts: Stage I: up to $135,000/year (2 years max) + 10% indirect; Stage II: up to $545,000 (18 months) + 10% indirect
Summary: Supports translational cancer research projects moving laboratory discoveries toward human clinical testing.
Key Information: Stage II applications require prior completion of Stage I milestones.
Description
Mission Boost Grants (MBG) are intended to accelerate the translation of laboratory-based cancer research into clinical application. These grants provide independent investigators at any career stage with additional resources to advance projects that are ready to move toward human testing. MBGs are structured in two stages: Stage I funds the development of outcome-specific milestones to reduce the risks associated with new drugs, devices, or procedures; Stage II supports the actual testing in cancer patients following the successful completion of Stage I. The program aims to bridge the critical gap between preclinical research and clinical implementation, ultimately expediting the development of impactful cancer therapies.
